Table:
begin	end	state
1	32	signal peptide
33	44	non-cytoplasmic
45	66	transmembrane
67	72	cytoplasmic
73	92	transmembrane
93	100	non-cytoplasmic
101	123	transmembrane
124	134	cytoplasmic
135	157	transmembrane
158	164	non-cytoplasmic
165	184	transmembrane
185	232	cytoplasmic
233	257	transmembrane
258	270	non-cytoplasmic
271	296	transmembrane
297	303	cytoplasmic
304	324	transmembrane
325	329	non-cytoplasmic
330	354	transmembrane
355	365	cytoplasmic
366	386	transmembrane
387	391	non-cytoplasmic
392	416	transmembrane
417	444	cytoplasmic

Input:
>WP_012112845.1 NCBI__GCF_000017645.1:WP_012112845.1
MKTLLLTASLVLLFGILFGFSTASIAGVVEAIAQAFALSTRATEMVVTSLLVGCFIGAAA
AAPVSARIGRRPACLLAAVLAMAGYSLIPLGQGVAPGAGMLVAARILIGLGVGLSSMVVP
MYAAEVTPARHRGAVVSLFQLAITLGILAGYAVPLALIGRASWQQMLGGGVLVAAACAAI
VLLLPESPRWLRSRGMSARADAAARALGISDEMGEEHAPDGANWRAVLGRGATGAVLVLC
SVLFVLQNFSGIDGILYYAPHIFTELGFPAGTAALAATFGLGLFNVIATIAAMALVDRLG
RRPLLIVGSAAMAVSLGAVIVAALADWPWVALAGLCAYIVAFALSLGPLPYVLMSELFPS
AIRERGIAVASATSWLFNGIVAGTFLSVVQGIGLAGTIGIFFVVCVLSLVVSVLFVPETR
RIGLEEIEADVLDGRPLRQLGAGG

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server